JP2009519950A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519950A5
JP2009519950A5 JP2008545854A JP2008545854A JP2009519950A5 JP 2009519950 A5 JP2009519950 A5 JP 2009519950A5 JP 2008545854 A JP2008545854 A JP 2008545854A JP 2008545854 A JP2008545854 A JP 2008545854A JP 2009519950 A5 JP2009519950 A5 JP 2009519950A5
Authority
JP
Japan
Prior art keywords
composition
polymeric material
composition according
activity
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008545854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519950A (ja
JP5558002B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/047967 external-priority patent/WO2007075447A2/en
Publication of JP2009519950A publication Critical patent/JP2009519950A/ja
Publication of JP2009519950A5 publication Critical patent/JP2009519950A5/ja
Application granted granted Critical
Publication of JP5558002B2 publication Critical patent/JP5558002B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008545854A 2005-12-16 2006-12-15 シュウ酸塩低減化のための組成物および方法 Expired - Fee Related JP5558002B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75089605P 2005-12-16 2005-12-16
US60/750,896 2005-12-16
PCT/US2006/047967 WO2007075447A2 (en) 2005-12-16 2006-12-15 Compositions and methods for oxalate reduction

Publications (3)

Publication Number Publication Date
JP2009519950A JP2009519950A (ja) 2009-05-21
JP2009519950A5 true JP2009519950A5 (https=) 2010-01-21
JP5558002B2 JP5558002B2 (ja) 2014-07-23

Family

ID=38218470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008545854A Expired - Fee Related JP5558002B2 (ja) 2005-12-16 2006-12-15 シュウ酸塩低減化のための組成物および方法

Country Status (11)

Country Link
US (2) US8900575B2 (https=)
EP (2) EP2366402A1 (https=)
JP (1) JP5558002B2 (https=)
CN (3) CN101405022A (https=)
AT (1) ATE499111T1 (https=)
AU (1) AU2006329844B2 (https=)
CA (1) CA2633238A1 (https=)
DE (1) DE602006020347D1 (https=)
ES (1) ES2362897T3 (https=)
HK (1) HK1201151A1 (https=)
WO (1) WO2007075447A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
ES2362897T3 (es) 2005-12-16 2011-07-14 Oxthera, Inc. Composiciones y métodos para reducción del oxalato.
PT2046373E (pt) 2006-08-02 2013-05-06 Althea Technologies Inc Oxalato descarboxilase cristalizada e métodos de utilização
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US8431122B2 (en) * 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
JP2012531186A (ja) * 2009-07-02 2012-12-10 オクステラ インテレクチュアル プロパティ エービー 組換えオキサレート分解酵素の精製及び単離並びにオキサレート分解酵素を含む噴霧乾燥粒子
DK2270138T3 (en) * 2009-07-02 2018-06-25 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate-degrading enzymes
EP2504428A4 (en) * 2009-11-25 2013-09-25 Captozyme Llc METHODS AND COMPOSITIONS FOR TREATING OXALATE RELATED DISEASES
ES2703513T3 (es) * 2011-04-07 2019-03-11 Histapharm Inc Composiciones enzimáticas orales para administración intestinal
WO2014113648A1 (en) 2013-01-18 2014-07-24 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
DK3003358T3 (da) 2013-06-07 2021-06-21 Allena Pharmaceuticals Inc Sammensætninger og anordninger til dialyse
EP3277099B9 (en) * 2015-04-02 2024-05-29 Oxidien Pharmaceuticals, Llc High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
CA3023042A1 (en) 2016-06-13 2017-12-21 Oxthera Intellectual Property Ab Compositions and methods for the treatment or prevention of oxalate-related disorders
WO2019092608A1 (en) * 2017-11-08 2019-05-16 Materias S.R.L. In situ gelifying powder
CN114903985A (zh) * 2021-02-10 2022-08-16 宁波倍益嘉生物科技有限公司 一种组合物及其在防治高草酸尿症方面的应用
GB2625234A (en) * 2021-09-09 2024-06-12 Unlocked Labs Inc Therapeutic engineered microbial cell systems and methods for treating conditions in which oxalate is detrimental
CN116444636B (zh) * 2023-04-17 2024-02-20 西南大学 抑制核盘菌的水稻OsGLP3-6及其应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
DE3030185A1 (de) 1980-08-07 1982-04-08 Kohlbecker, Günther, 3000 Hannover Verfahren zur enzymatischen entfernung von oxalat mittels oxalat-oxidase
DE3204284A1 (de) 1982-02-06 1983-08-18 Kohlbecker, Günther, 3000 Hannover Verfahren zur enzymatischen entfernung von sauerstoff
JPS5968344A (ja) 1982-10-12 1984-04-18 Agency Of Ind Science & Technol 非対称機能膜及びその製法
US4539118A (en) 1984-03-23 1985-09-03 Sigma Chemical Company Rapid, accurate method of separation of oxalate from urine and other biological fluids
US5263992A (en) 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
US5286495A (en) 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
EP0673416A1 (en) 1992-11-30 1995-09-27 Zeneca Limited Oxalate decarboxylase
EP0693884A4 (en) 1993-04-16 1996-03-27 Mccormick & Co Inc ENCLOSURE COMPOSITIONS
US5554147A (en) 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
US5788687A (en) 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5505713A (en) 1994-04-01 1996-04-09 Minimed Inc. Indwelling catheter with stable enzyme coating
EP0764204B1 (en) 1994-05-18 2001-08-22 Human Genome Sciences, Inc. HUMAN OXALYL-CoA DECARBOXYLASE
US6214980B1 (en) 1994-06-20 2001-04-10 University Of Florida Materials and methods for detection of Oxalobacte formigenes
US6090628A (en) 1994-06-20 2000-07-18 University Of Florida Materials and methods for detection of Oxalobactor formigenes
US5604111A (en) 1994-06-20 1997-02-18 University Of Florida Research Foundation Method and kit for detection of oxalate
US5912125A (en) 1994-06-20 1999-06-15 University Of Florida Materials and methods for detection of oxalobacter
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
US6033719A (en) 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
SE9603029D0 (sv) 1996-08-20 1996-08-20 Svenska Traeforskningsinst Method for lowering the level of oxalic acid
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
CA2266581C (en) * 1996-09-19 2007-03-13 The Regents Of The University Of Michigan Polymers containing polysaccharides such as alginates or modified alginates
US6297425B1 (en) 1997-03-21 2001-10-02 Pioneer Hi-Bred International, Inc. Gene encoding oxalate decarboxylase from aspergillus phoenices
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
PT983076E (pt) * 1997-05-23 2010-01-05 Oxthera Inc Microrganismos de degradação de oxalato ou enzimas de degradação de oxalato para prevenir doenças relacionadas com oxalato
US20040120941A1 (en) * 1997-05-23 2004-06-24 Allison Milton J. Materials and methods for treating or preventing oxalate-related disease
US6161499A (en) * 1997-07-07 2000-12-19 Cvd Diamond Corporation Apparatus and method for nucleation and deposition of diamond using hot-filament DC plasma
US6080404A (en) 1997-09-05 2000-06-27 University Of Florida Materials and methods for removal of substances from fluids
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
AU3743099A (en) * 1998-04-24 1999-11-16 Onyx Pharmaceuticals, Inc. Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
JP5068401B2 (ja) 1998-09-28 2012-11-07 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ Hpmcカプセルを使用する腸及び結腸への送達
DE69940821D1 (de) 1998-10-09 2009-06-10 Gen Mills Inc Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
IT1309427B1 (it) 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
TR200103540T2 (tr) 1999-06-07 2002-04-22 Nanosphere Inc. Partikül kaplama yöntemleri ve bu şekilde üretilen partiküller.
NZ526443A (en) 2000-12-18 2005-03-24 Probiohealth Llc Probiotic compounds derived from lactobacillus casei strain KE01
US7407668B2 (en) 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
US6929940B1 (en) 2002-08-20 2005-08-16 University Of Florida Research Foundation, Inc. Polynucleotides encoding oxalate decarboxylase from Aspergillus niger and methods of use
NL1021879C2 (nl) * 2002-11-08 2004-05-11 Univ Delft Tech Werkwijze voor het bereiden van vernette enzymdeeltjes.
WO2005060937A1 (en) 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
EP1755655A4 (en) * 2004-05-07 2011-03-30 Oxthera Inc METHOD AND COMPOSITIONS FOR REDUCING OXALATE CONCENTRATIONS
PT1962873E (pt) 2005-12-14 2013-08-29 Oxthera Inc Composições farmacêuticas compreendendo bactérias redutoras de oxalato
ES2362897T3 (es) 2005-12-16 2011-07-14 Oxthera, Inc. Composiciones y métodos para reducción del oxalato.
PT2046373E (pt) 2006-08-02 2013-05-06 Althea Technologies Inc Oxalato descarboxilase cristalizada e métodos de utilização
US8431122B2 (en) 2009-07-02 2013-04-30 Oxthera Intellectual Property Ab Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes

Similar Documents

Publication Publication Date Title
JP2009519950A5 (https=)
Ren et al. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation
Atiroğlu et al. Immobilization of α-amylase enzyme on a protein@ metal–organic framework nanocomposite: a new strategy to develop the reusability and stability of the enzyme
Hu et al. Integration of cellulases into bacterial cellulose: toward bioabsorbable cellulose composites
Kim et al. Synthesis and characterization of injectable poly (N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links
Kosaraju Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery
Park et al. Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability
Chan et al. Production of alginate microspheres by internal gelation using an emulsification method
Alatawi et al. Amino functionalization of carboxymethyl cellulose for efficient immobilization of urease
Gómez et al. Immobilization of chitosan-modified invertase on alginate-coated chitin support via polyelectrolyte complex formation
Sakloetsakun et al. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents
JPWO2019043134A5 (https=)
CA2514539A1 (en) Process for producing coated preparation
Sakai et al. Control of cellular adhesiveness in an alginate-based hydrogel by varying peroxidase and H2O2 concentrations during gelation
JP2002524100A (ja) ポリマー固定生細胞、およびその利用
Ulbrich et al. Molecular characterization of acid‐thinned wheat, potato and pea starches and correlation to gel properties
Delanoy et al. Activity and stability of laccase in conjugation with chitosan
CN110215536B (zh) 针对糖尿病创面的细菌纤维素水凝胶敷料及其制备方法
Kang et al. pH-induced volume-phase transition of hydrogels containing sulfonamide side group by reversible crystal formation
WO2024159712A1 (zh) 一种天然持久抗菌的超疏水纤维素织物及其制备方法
Fetzner et al. Degradation of raw or film-incorporated β-cyclodextrin by enzymes and colonic bacteria
Du et al. Dual‐Cross‐Linked Chitosan‐Based Antibacterial Hydrogels with Tough and Adhesive Properties for Wound Dressing
Pervez et al. Role of two polysaccharide matrices on activity, stability and recycling efficiency of immobilized fungal amyloglucosidase of GH15 family
JP3647859B2 (ja) 酵素的に制御された薬剤放出のための架橋されたポリヒドロキシ材料
CN107619645A (zh) 一种基于全酶法制备多巴胺增强淀粉基粘合剂的方法